Recent studies show that FOXO1 promotes inflammation during diabetes by enhancing TLR4-mediated signaling, suggesting FOXO1 as a key mediator of inflammatory responses during obesity and diabetes [49]. This evidence concerns the gene TLR4 and diabetes mellitus.